Pulmonary embolism is the second leading cause of death in the United States, right behind heart disease. Around 300,000 people die each year due to pulmonary embolism, and deep vein thrombosis ...

Rivaroxaban(Xarelto, Janssen) received FDA approval today for the prevention of deep vein thrombosis which may lead to a pulmonary embolism in patients undergoing knee or hip replacement surgery. The ...

Stockholm, Sweden - A new randomized trial shows no benefit from the use of thigh-length graduated compression stockings (GCS) to prevent proximal deep vein thrombosis (DVT) in patients immobilized by ...

Among patients who underwent total hip or total knee arthroplasty, aspirin did not differ significantly from rivaroxaban (Xarelto, Janssen Pharmaceutica) for prevention of proximal deep-vein ...

XARELTO (rivaroxaban) 20mg tablets Janssen Pharmaceuticals announced FDA approval of Xarelto (rivaroxaban) tablets for the prevention of deep vein thrombosis (DVT) that may lead to a pulmonary ...

The FDA today expanded the indication for rivaroxaban (Xarelto, Johnson & Johnson) to include the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and to reduce the risk of ...

If you suspect that you may have developed a DVT, you should immediately contact your physician or go to an emergency room. Be sure to mention that you have recently completed a long journey, as that ...

As well as preventing DVT the company indicates that PlasmFlow can be used to enhance blood circulation, reduce post-operative pain and swelling, aid in the treatment of stasis dermatitis, venous ...

Pune, Maharashtra, India, March 26 2021 (Wiredrelease) MarketDesk –:The market research report labeled as Global Intermittent Pneumatic Compression for DVT Prevention Market typically offers the ...

Study design: Prospective clinical trial. Objectives: To evaluate the efficacy of a specific protocol for prevention of thrombo-embolic disease occurring during the acute stage of spinal cord lesions, ...